TAXIS PHARMACEUTICALS
Company Overview
Social Media Profiles
About TAXIS Pharmaceuticals
Description
TAXIS Pharmaceuticals is at the forefront of combating antimicrobial resistance. By developing innovative therapies that target the foundational survival mechanisms of bacteria, the company aims to revolutionize treatment approaches, ensuring a future where antimicrobial resistance does not threaten global health.
Specialties
Innovative Antimicrobial Therapies
Targeting Bacterial Survival Mechanisms
Development of TXA709 for MRSA
Focus on Gram-Negative Bacteria
Qualified Infectious Disease Product (QIDP)
Products & Services
Antimicrobial Therapies
Anti-MRSA Agents
Targeted Bacterial Treatments
Infectious Disease Solutions
Innovative Biopharmaceuticals
Contact Information
No contact information available
Competitors & Similar Companies(9)
Avir Pharma
CureVac AG
Moderna, Inc.
Aridis Pharmaceuticals
ReViral Limited
Vaxart, Inc.
Paratek Pharmaceuticals
Spero Therapeutics
Summit Therapeutics
News & Media
Search Terms:
taxis pharmaceuticals
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Featured News
No news found for TAXIS Pharmaceuticals
Frequently Asked Questions about TAXIS Pharmaceuticals
Where is TAXIS Pharmaceuticals located?
The headquarter of TAXIS Pharmaceuticals is located in Monmouth Junction, New Jersey, United States
What is the official website of TAXIS Pharmaceuticals?
The official website of TAXIS Pharmaceuticals is https://www.taxispharma.com
What industry does TAXIS Pharmaceuticals belong to?
TAXIS Pharmaceuticals belongs to the Biotechnology, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of TAXIS Pharmaceuticals?
TAXIS Pharmaceuticals specializes in Innovative Antimicrobial Therapies, Targeting Bacterial Survival Mechanisms, Development of TXA709 for MRSA, Focus on Gram-Negative Bacteria, Qualified Infectious Disease Product (QIDP).
What products and services is TAXIS Pharmaceuticals likely to offer?
TAXIS Pharmaceuticals offers Antimicrobial Therapies, Anti-MRSA Agents, Targeted Bacterial Treatments, Infectious Disease Solutions, Innovative Biopharmaceuticals.
Who are the competitors of TAXIS Pharmaceuticals?
Competitors of TAXIS Pharmaceuticals are Avir Pharma, CureVac AG, Moderna, Inc., Aridis Pharmaceuticals, ReViral Limited, Vaxart, Inc., Paratek Pharmaceuticals, Spero Therapeutics, Summit Therapeutics.
What does TAXIS Pharmaceuticals do?
TAXIS Pharmaceuticals is at the forefront of combating antimicrobial resistance. By developing innovative therapies that target the foundational survival mechanisms of bacteria, the company aims to revolutionize treatment approaches, ensuring a future where antimicrobial resistance does not threaten global health.
What are the social media links of TAXIS Pharmaceuticals?
Social media links of TAXIS Pharmaceuticals areLinkedIn